- Home
- XERS vs CFFN Comparison
XERS vs CFFN Comparison
Compare XERS & CFFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- CFFN
- Stock Information
- Founded
- XERS 2005
- CFFN 1893
- Country
- XERS United States
- CFFN United States
- Employees
- XERS N/A
- CFFN N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- CFFN Savings Institutions
- Sector
- XERS Health Care
- CFFN Finance
- Exchange
- XERS Nasdaq
- CFFN Nasdaq
- Market Cap
- XERS 752.7M
- CFFN 823.4M
- IPO Year
- XERS 2018
- CFFN 1999
- Fundamental
- Price
- XERS $5.29
- CFFN $6.22
- Analyst Decision
- XERS Strong Buy
- CFFN Hold
- Analyst Count
- XERS 6
- CFFN 2
- Target Price
- XERS $6.25
- CFFN $6.50
- AVG Volume (30 Days)
- XERS 2.2M
- CFFN 823.7K
- Earning Date
- XERS 08-07-2025
- CFFN 07-23-2025
- Dividend Yield
- XERS N/A
- CFFN 5.47%
- EPS Growth
- XERS N/A
- CFFN N/A
- EPS
- XERS N/A
- CFFN 0.40
- Revenue
- XERS $222,551,000.00
- CFFN $184,847,000.00
- Revenue This Year
- XERS $35.03
- CFFN $9.86
- Revenue Next Year
- XERS $18.31
- CFFN $10.13
- P/E Ratio
- XERS N/A
- CFFN $15.38
- Revenue Growth
- XERS 29.88
- CFFN N/A
- 52 Week Low
- XERS $2.10
- CFFN $4.90
- 52 Week High
- XERS $6.07
- CFFN $7.20
- Technical
- Relative Strength Index (RSI)
- XERS 62.91
- CFFN 62.54
- Support Level
- XERS $5.00
- CFFN $6.31
- Resistance Level
- XERS $5.49
- CFFN $6.36
- Average True Range (ATR)
- XERS 0.24
- CFFN 0.12
- MACD
- XERS 0.08
- CFFN 0.00
- Stochastic Oscillator
- XERS 79.38
- CFFN 73.49
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About CFFN Capitol Federal Financial Inc.
Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank, Capitol Federal Savings Bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It primarily serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.